Simple and effective serum biomarkers potential for predicting status epilepticus in anti-N-methyl-D-aspartate receptor encephalitis

Table 2 Serum UA, HDL-C and UA levels in the two groups of anti-NMDAR encephalitis patients

Variables	non-SE		SE		p1	p2	p3
Variables	Before treatment	After treatment	Before treatment	After treatment	p1	p2	p3
UA	288.82 ± 91.32	292.18 ± 80.48	222.68 ± 77.53	310.75 ± 79.95	0.866	0.003	0.467
HDL-C	1.33 ± 0.56	1.33 ± 0.45	0.94 ± 0.25	1.17 ± 0.26	0.999	0.018	0.274
CRP	3.59 ± 4.03	3.10 ± 3.81	7.96 ± 8.95	1.61 ± 0.26	0.624	0.010	0.068

p1: before treatment vs. 3 months after treatment of no-SE group; p2: before treatment vs. 3 months after treatment of SE group; p3: non-SE group vs. SE group 3 months after treatment; anti-NMDAR, anti-N-methyl-D-aspartate receptor; non-SE, non-status epilepticus; SE Status epilepticus, UA Uric acid, HDL-C High density lipoprotein cholesterol, CRP C-reactive protein.

ISSN: 1471-2377